Literature DB >> 33526216

Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants, Newly Identified Molecular Characteristics, and Emerging Treatment Modalities.

Mobeen Rahman1, Christopher C Griffith2.   

Abstract

Salivary duct carcinoma (SDC) is a rare, aggressive salivary gland malignancy with significant mortality. Morphologically, most tumors are characterized by apocrine differentiation with a typical immunophenotype of androgen receptor positive/gross cystic disease fluid protein positive/estrogen receptor negative/progesterone receptor negative. Several morphologic variants of SDC exist, representing diagnostic pitfalls. Several differential diagnoses should be considered because prognosis, treatment, and management may be different from SDC. For SDC, current treatment strategies are aggressive and commonly include surgical excision with lymph node dissection and adjuvant radiotherapy. Continued research is examining the utility of androgen deprivation therapy and targeted molecular therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Apocrine; Molecular; Salivary duct carcinoma; Salivary gland

Year:  2021        PMID: 33526216     DOI: 10.1016/j.path.2020.09.010

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  1 in total

1.  Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.

Authors:  Di Zhang; Lixi Li; Tingyu Wen; Fei Ma
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-29       Impact factor: 3.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.